Clinical impact of very early recurrence after conversion surgery for stage IV gastric cancer.
Atsushi MoritoKojiro EtoMasaaki IwatsukiTasuku ToihataKeisuke KosumiShiro IwagamiYoshifumi BabaYuji MiyamotoNaoya YoshidaHideo BabaPublished in: Annals of gastroenterological surgery (2023)
CS is an effective treatment for stage IV GC, but VER is associated with poor prognosis. We need to carefully consider the indications for CS, especially for patients with poor nutritional status and liver metastases.